Single-cell RNA sequencing indicated that the effector CD8+ T cells in advanced HCC patients were depleted and weakened in cytotoxicity compared to those in early-stage of HCC, which may lead to impaired anti-tumor function (34). This evidence concerns the gene CD8A and hepatocellular carcinoma.